MAM-2201

From WikiMD's WELLNESSPEDIA

Chemical structure of MAM-2201

MAM-2201 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is a member of the indole family of synthetic cannabinoids and is structurally related to other compounds such as JWH-018 and AM-2201.

Chemical Properties[edit]

MAM-2201 is chemically known as 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole. It is a fluorinated derivative of AM-2201, with the addition of a methyl group on the naphthoyl ring. This modification enhances its binding affinity to the CB1 and CB2 receptors, making it a highly potent synthetic cannabinoid.

Pharmacology[edit]

MAM-2201 acts as a full agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors are involved in a variety of physiological processes including pain sensation, mood, and memory. The activation of these receptors by MAM-2201 can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.

Effects and Usage[edit]

The effects of MAM-2201 are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, altered perception, and increased appetite. However, due to its high potency, it can also cause adverse effects such as anxiety, paranoia, and tachycardia. MAM-2201 has been used recreationally, often sprayed onto herbal mixtures and sold as "spice" or "K2."

Legal Status[edit]

Due to its potential for abuse and lack of medical use, MAM-2201 has been classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.